Activation and expansion of T-cells using an engineered multivalent signaling platform
US7638325B2 · kind B2 · utility
23Cited by
20References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 3, 2003 |
| Grant date | Dec 29, 2009 |
| Priority date | — |
| Expiry date | Apr 30, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2510/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to methods for activating and expanding cells, and more particularly, to a novel method to activate and/or stimulate cells using an engineered multivalent signaling platform. Compositions of cells activated and expanded by the methods herein are further provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.